Literature DB >> 26854137

Modeling autism spectrum disorders with human neurons.

Patricia C B Beltrão-Braga1, Alysson R Muotri2.   

Abstract

Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders characterized by impaired social communication and interactions and by restricted and repetitive behaviors. Although ASD is suspected to have a heritable or sporadic genetic basis, its underlying etiology and pathogenesis are not well understood. Therefore, viable human neurons and glial cells produced using induced pluripotent stem cells (iPSC) to reprogram cells from individuals affected with ASD provide an unprecedented opportunity to elucidate the pathophysiology of these disorders, providing novel insights regarding ASD and a potential platform to develop and test therapeutic compounds. Herein, we discuss the state of art with regards to ASD modeling, including limitations of this technology, as well as potential future directions. This article is part of a Special Issue entitled SI: Exploiting human neurons.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autism spectrum disorders; Disease modeling; Human induced pluripotent stem cells; Human neurons

Mesh:

Year:  2016        PMID: 26854137      PMCID: PMC4975680          DOI: 10.1016/j.brainres.2016.01.057

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  69 in total

1.  iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.

Authors:  Matthew E Doers; Michael T Musser; Robert Nichol; Erich R Berndt; Mei Baker; Timothy M Gomez; Su-Chun Zhang; Leonard Abbeduto; Anita Bhattacharyya
Journal:  Stem Cells Dev       Date:  2014-04-30       Impact factor: 3.272

Review 2.  Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises.

Authors:  Maria C Marchetto; Kristen J Brennand; Leah F Boyer; Fred H Gage
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

Review 3.  Neurobehavioral phenotype in Prader-Willi syndrome.

Authors:  Joyce Whittington; Anthony Holland
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-11-15       Impact factor: 3.908

4.  Detecting, studying, and treating autism early: the one-year well-baby check-up approach.

Authors:  Karen Pierce; Cindy Carter; Melanie Weinfeld; Jamie Desmond; Roxana Hazin; Robert Bjork; Nicole Gallagher
Journal:  J Pediatr       Date:  2011-04-27       Impact factor: 4.406

Review 5.  Prader-Willi syndrome: clinical genetics, cytogenetics and molecular biology.

Authors:  Douglas C Bittel; Merlin G Butler
Journal:  Expert Rev Mol Med       Date:  2005-07-25       Impact factor: 5.600

6.  Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms.

Authors:  H L Wilson; A C C Wong; S R Shaw; W-Y Tse; G A Stapleton; M C Phelan; S Hu; J Marshall; H E McDermid
Journal:  J Med Genet       Date:  2003-08       Impact factor: 6.318

7.  TRPC6 channels promote dendritic growth via the CaMKIV-CREB pathway.

Authors:  Yilin Tai; Shengjie Feng; Ruiliang Ge; Wanlu Du; Xiaoxing Zhang; Zhuohao He; Yizheng Wang
Journal:  J Cell Sci       Date:  2008-06-17       Impact factor: 5.285

8.  Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells.

Authors:  Achia Urbach; Ori Bar-Nur; George Q Daley; Nissim Benvenisty
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

9.  Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders.

Authors:  Brian J O'Roak; Laura Vives; Wenqing Fu; Jarrett D Egertson; Ian B Stanaway; Ian G Phelps; Gemma Carvill; Akash Kumar; Choli Lee; Katy Ankenman; Jeff Munson; Joseph B Hiatt; Emily H Turner; Roie Levy; Diana R O'Day; Niklas Krumm; Bradley P Coe; Beth K Martin; Elhanan Borenstein; Deborah A Nickerson; Heather C Mefford; Dan Doherty; Joshua M Akey; Raphael Bernier; Evan E Eichler; Jay Shendure
Journal:  Science       Date:  2012-11-15       Impact factor: 47.728

10.  Autistic children at risk of being underestimated: school-based pilot study of a strength-informed assessment.

Authors:  Valérie Courchesne; Andrée-Anne S Meilleur; Marie-Pier Poulin-Lord; Michelle Dawson; Isabelle Soulières
Journal:  Mol Autism       Date:  2015-03-06       Impact factor: 7.509

View more
  7 in total

1.  CNTN5-/+or EHMT2-/+human iPSC-derived neurons from individuals with autism develop hyperactive neuronal networks.

Authors:  Eric Deneault; Muhammad Faheem; Sean H White; Deivid C Rodrigues; Song Sun; Wei Wei; Alina Piekna; Tadeo Thompson; Jennifer L Howe; Leon Chalil; Vickie Kwan; Susan Walker; Peter Pasceri; Frederick P Roth; Ryan Kc Yuen; Karun K Singh; James Ellis; Stephen W Scherer
Journal:  Elife       Date:  2019-02-12       Impact factor: 8.140

2.  Low-Density Neuronal Cultures from Human Induced Pluripotent Stem Cells.

Authors:  Peter Dimitrion; Yun Zhi; Dennis Clayton; Gerard L Apodaca; Madeleine R Wilcox; Jon W Johnson; Vishwajit Nimgaonkar; Leonardo D'Aiuto
Journal:  Mol Neuropsychiatry       Date:  2017-06-17

Review 3.  Adhesion G Protein-Coupled Receptors as Drug Targets for Neurological Diseases.

Authors:  Christopher J Folts; Stefanie Giera; Tao Li; Xianhua Piao
Journal:  Trends Pharmacol Sci       Date:  2019-03-11       Impact factor: 14.819

Review 4.  Lessons learned from studying syndromic autism spectrum disorders.

Authors:  Yehezkel Sztainberg; Huda Y Zoghbi
Journal:  Nat Neurosci       Date:  2016-10-26       Impact factor: 24.884

Review 5.  Studying human disease using human neurons.

Authors:  Tim Ahfeldt; Nadia K Litterman; Lee L Rubin
Journal:  Brain Res       Date:  2016-04-06       Impact factor: 3.252

Review 6.  Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity.

Authors:  Anna Bal-Price; M E Bette Meek
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

Review 7.  Genomics of autism spectrum disorder: approach to therapy.

Authors:  Fatma Ayhan; Genevieve Konopka
Journal:  F1000Res       Date:  2018-05-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.